Erlotinib Tablets IP

Description

We are offering Erlotinib Tablets IP which is a Kinase inhibitor which is primarily used to treat cell lung cancer, or pancreatic cancer when combined with a certain other medications. It works by inhibiting growth to adjacent tissues in the body so that the cancerous cells slow down, allowing the patient a better environment to recover and fight cancer naturally.Dosage and Administration: Typically, an adult patient will be instructed to take between 100mg and 150mg of Erlonat (Erlotinib), at least 1 hour before any meals or snacks and 2 hours after. Unless otherwise instructed, you should always swallow each tablet whole without chewing, crushing, splitting, or dissolving the tablet in liquid. Wash tablets down with full glass of water.